BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 15662521)

  • 21. Long-term clinical outcomes following en bloc resections for sacral chordomas and chondrosarcomas: a series of twenty consecutive patients.
    Hsieh PC; Xu R; Sciubba DM; McGirt MJ; Nelson C; Witham TF; Wolinksy JP; Gokaslan ZL
    Spine (Phila Pa 1976); 2009 Sep; 34(20):2233-9. PubMed ID: 19752710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aspiration cytology and immunocytochemistry of sacral chordoma with liver metastases: a case report.
    Perasole A; Infantolino D; Spigariol F
    Diagn Cytopathol; 1991; 7(3):277-81. PubMed ID: 1879264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sacral chordoma, gas gangrene and bilateral renal cell carcinomas.
    Harrington KJ; Kelly LF; Pandha HS; McKenzie CG
    Clin Oncol (R Coll Radiol); 1996; 8(2):123-4. PubMed ID: 8859613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lumbo-sacral chordoma with high-grade malignant cartilaginous and spindle cell components.
    Hruban RH; May M; Marcove RC; Huvos AG
    Am J Surg Pathol; 1990 Apr; 14(4):384-9. PubMed ID: 1690955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surgical treatment of sacral chordomas combined with transcatheter arterial embolization.
    Yang H; Zhu L; Ebraheim NA; Liu J; Shapiro A; Castillo S; Liu X; Tang T
    J Spinal Disord Tech; 2010 Feb; 23(1):47-52. PubMed ID: 20084025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benign notochordal cell tumour: case report.
    Souteyrand P; Bouvier C; Zink JV; Chapon F; Marciano S; André M; Chagnaud C
    Diagn Interv Imaging; 2013 Apr; 94(4):466-9. PubMed ID: 23491213
    [No Abstract]   [Full Text] [Related]  

  • 27. Value of MRI in the diagnosis of non-clival, non-sacral chordoma.
    Smolders D; Wang X; Drevelengas A; Vanhoenacker F; De Schepper AM
    Skeletal Radiol; 2003 Jun; 32(6):343-50. PubMed ID: 12719927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Sacrococcygeal chordoma with malignant spindle cell components. Case report and review of the literature].
    Woenckhaus J; Benedix P; Holotiuk O; Riedel H; Justus J
    Pathologe; 1997 Sep; 18(5):395-400. PubMed ID: 9432676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intensity modulated radiotherapy in the management of sacral chordoma in primary versus recurrent disease.
    Zabel-du Bois A; Nikoghosyan A; Schwahofer A; Huber P; Schlegel W; Debus J; Milker-Zabel S
    Radiother Oncol; 2010 Dec; 97(3):408-12. PubMed ID: 21056488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sacral chordoma in early childhood: clinicopathological and immunohistochemical study.
    Iwasa Y; Nakashima Y; Okajima H; Morishita S
    Pediatr Dev Pathol; 1998; 1(5):420-6. PubMed ID: 9688766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pulmonary vein metastasis of a sacral chordoma extending into the left atrial cavity.
    Prompona M; Linn J; Burdorf L; Assmann G; Reichart B; Reiser M; Nikolaou K
    J Cardiovasc Med (Hagerstown); 2009 Jul; 10(7):557-9. PubMed ID: 19384241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term outcome following surgical treatment of sacral chordoma.
    Osaka S; Osaka E; Kojima T; Yoshida Y; Tokuhashi Y
    J Surg Oncol; 2014 Mar; 109(3):184-8. PubMed ID: 24249252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Value of CT and NMR imaging in diagnosing of chordomas.
    Woźnica J; Kendall B; Bryc S; Losicki M; Kingsley D
    Ann Univ Mariae Curie Sklodowska Med; 1990; 45():181-6. PubMed ID: 1670023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hand metastasis from a sacral chordoma.
    Emori M; Kaya M; Sugita S; Soma T; Sasaki M; Yamashita T
    Ann R Coll Surg Engl; 2014 Nov; 96(8):e8-11. PubMed ID: 25350167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A review of the surgical management of sacral chordoma.
    Kayani B; Hanna SA; Sewell MD; Saifuddin A; Molloy S; Briggs TW
    Eur J Surg Oncol; 2014 Nov; 40(11):1412-20. PubMed ID: 24793103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of Raf-1 and ERK1/2 in sacral chordoma and association with tumor recurrence.
    Zhang K; Chen H; Zhang B; Sun J; Lu J; Chen K; Yang H
    Int J Clin Exp Pathol; 2015; 8(1):608-14. PubMed ID: 25755752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High expression of survivin in sacral chordoma.
    Chen C; Yang HL; Chen KW; Wang GL; Lu J; Yuan Q; Gu YP; Luo ZP
    Med Oncol; 2013 Jun; 30(2):529. PubMed ID: 23504337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of carbon ion radiotherapy for sacral chordoma: results of Phase I-II and Phase II clinical trials.
    Imai R; Kamada T; Tsuji H; Sugawara S; Serizawa I; Tsujii H; Tatezaki S;
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1470-6. PubMed ID: 19939576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A case report of sacral chordoma].
    Lin Y; Furukawa M; Nakata T; Setoguchi M; Kusano T; Tashiro K; Matsumoto T
    Nihon Geka Gakkai Zasshi; 1989 Jan; 90(1):145-8. PubMed ID: 2704362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Autopsy case of simultaneous triple malignancies--ovarian, chordoma and thyroid cancers].
    Yamamoto Y; Moriwaki S; Takashima S; Yumoto Y
    Gan No Rinsho; 1983 Sep; 29(11):1375-8. PubMed ID: 6632220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.